SCHEMBL24144036

SCHEMBL24144036

CCC(C)n1cc(CCN)c2ccc(-c3ccncc3)cc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1D1 P20393 4/20 0.44
▸ AAK1 Q2M2I8 6/20 0.37
▸ LRRK2 Q5S007 1/20 0.36
▸ METAP2 P50579 3/20 0.35
▸ CHEK1 O14757 1/20 0.35
▸ HTR2A P28223 1/20 0.35
▸ NR3C1 P04150 2/20 0.34
▸ PGR P06401 2/20 0.34
▸ NR3C2 P08235 2/20 0.34
▸ AR P10275 2/20 0.34
▸ ROCK2 O75116 1/20 0.34
▸ CDK1 P06493 1/20 0.34
▸ PRKACA P17612 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ CSNK1D P48730 1/20 0.34
▸ GSK3A P49840 1/20 0.34
▸ CDK5 Q00535 1/20 0.34
▸ PRKCD Q05655 1/20 0.34
▸ ROCK1 Q13464 1/20 0.34
▸ CDC42BPA Q5VT25 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24143742 0.89 NR1D1 (0.47) NR1D1AAK1METAP2CHEK1HTR2A
SCHEMBL24144846 0.87 NR1D1 (0.45) NR1D1AAK1LRRK2METAP2CHEK1
SCHEMBL24144342 0.81 NR1D1 (0.48) NR1D1AAK1ROCK2CDK1PRKACA
SCHEMBL24143743 0.80 NR1D1 (0.50) NR1D1AAK1METAP2CHEK1HTR2A
SCHEMBL24143036 0.80 HTR2A (0.54) NR1D1AAK1METAP2CHEK1HTR2A
SCHEMBL24142979 0.80 NR1D1 (0.67) NR1D1
SCHEMBL24142869 0.79 NR1D1 (0.39) NR1D1AAK1CHEK1HTR2AROCK2
SCHEMBL26675188 0.79 HTR2A (0.39) CHEK1HTR2ANR3C1PGRNR3C2
SCHEMBL24144465 0.78 NR1D1 (0.48) NR1D1AAK1METAP2CHEK1HTR2A
SCHEMBL24143542 0.78 NR1D1 (0.53) NR1D1AAK1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021263278-A1 REV-ERB AGONISTS FOR THE TREATMENT OF TH17-MEDIATED INFLAMMATORY DISORDERS THE SCRIPPS RESEARCH INSTITUTE (US) 2021-12-30 — — WO disclosed
Send feedback